CynergisTek Launches New Continuous Risk Monitoring Program (CRMP) and Signs First Six-Figure Contract With Southeastern Hospital
28 Avril 2022 - 1:00PM
Business Wire
CynergisTek’s new CRMP services bundle provides client with a
customizable platform to ramp up cybersecurity and meet
requirements of cyberinsurance providers
CynergisTek (NYSE American: CTEK), leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, announces the launching of its new Continuous Risk
Monitoring Program (CRMP) and its first contract, a six-figure
agreement with a Southeastern hospital. This three-year contract
will provide continuous threat monitoring services, establish
countermeasures to combat ransomware and malicious attacks, and
meet cyberinsurance requirements that will ensure lower
premiums.
Small, rural healthcare providers have long been targets for bad
actors preying on their limited cybersecurity budgets, outdated
technologies, and minimal dedicated security resources. In 2021,
the healthcare industry saw significant changes to cyber insurance
requirements, including increases to premiums and decreases in
coverage based on the risk that healthcare organizations present to
their insurers due to immature cyber risk programs and heightened
cyber threat. CynergisTek has recognized the need for a partner to
aid in addressing these challenges head on in a practical,
cost-effective manner and is providing a combination of world-class
cybersecurity technology solutions and services that include
Multi-Factor Authentication, Endpoint Protection, Threat Alerting
and Monitoring, Advanced Analytics, IoT, Privileged Access
Management, Ransomware Readiness, and Continuous Security
Validation in customizable bundles and preferred pricing. By
developing a comprehensive, ongoing, fully managed program into one
seamless service offering, CynergisTek can aid clients in
developing a more secure environment, address evolving threats such
as ransomware, and ultimately reduce overall risk exposure.
“This is where industry know how, innovation, and out of the box
thinking meets need in a meaningful way,” said Mac McMillan, CEO
& President of CynergisTek. “Small to medium sized healthcare
entities have been struggling for some time to try to keep up with
the cybercriminals that pursue them just as relentlessly as their
larger counterparts. Cyberinsurance requirements to add more
technology have only exacerbated the challenges they are already
having trouble facing, with little hope for improvement in their
security posture. Simply adding more tech, even the right tech, if
you can’t manage or monitor it effectively won’t resolve the
underlying problem. We know this from the hundreds of assessments
and tests we run every year, which is why we at CynergisTek have
worked with partners to develop a customizable and managed solution
that recognizes the unique needs of each client, meets insurance
requirements, and improves security.”
“Our goal is to provide customers with an innovative technology
stack coupled with ongoing managed services that enables
organizations to be in the best position to identify, prevent, and
defend the ever-evolving tools, techniques, and procedures of
threat actors. Our Continuous Risk Monitoring Program provides
these capabilities while providing 24x7/365 eyes-on-glass
monitoring with an affordable pricing model that scales to all
sized organizations and, unlike many solutions today, offers a
totally predictable long-term total cost of ownership,” said Ben
Denkers, CIO of CynergisTek.
By providing small, rural healthcare providers with access to
the same levels of protection that have historically been seen in
large enterprise organizations, hospitals are now armed with the
tools and expertise required to protect themselves across the full
threat landscape. CynergisTek helps organizations with fewer
resources develop a well-rounded cybersecurity program and
strengthen their cybersecurity posture. Maintaining an active risk
management program is vital to building resilience in healthcare
organizations and the industry, which is a cornerstone of the
CynergisTek mission.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity consulting firm
helping organizations in highly-regulated industries, including
those in healthcare, government, and finance navigate emerging
security and privacy issues. CynergisTek combines intelligence,
expertise, and a distinct methodology to validate a company’s
security posture and ensure the team is rehearsed, prepared, and
resilient against threats. Since 2004, CynergisTek has been
dedicated to hiring and retaining experts who bring real-life
experience and hold advanced certifications to support and educate
the industry by contributing to relevant industry associations. For
more information, visit www.cynergistek.com or follow us on Twitter
or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of the COVID-19
pandemic, including actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets; the general economic impact
of the ongoing war in Ukraine, including the impact of related
sanctions being imposed by the U.S. Government and the governments
of other countries, and the impact of potential reprisals as a
consequence of the war in Ukraine and any related sanctions; and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Certain of these risks and uncertainties are
or will be described in greater detail in the Company’s Form 10-K
and Form 10-Q filings with the Securities and Exchange Commission,
which are available at http://www.sec.gov. Given the risks and
uncertainties, readers should not place undue reliance on any
forward-looking statement and should recognize that the statements
are predictions of future results which may not occur as
anticipated. Many of the risks listed above have been, and may
further be, exacerbated by the COVID-19 pandemic, including its
impact on the healthcare industry, or the ongoing war in Ukraine.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220428005485/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x7 InvestorRelations@cynergistek.com
CynergisTek Media Contact: CynergisTek, Inc. Trinity
McPherson (443) 853-8468 trinity.mcpherson@cynergistek.com
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024